CDK2-IN-21
CDK2-IN-21 (example 30) is a potent cyclin-dependent kinase 2 (CDK2) inhibitor with an IC50 of 0.24 µM. CDK2-IN-21 can be used for cancer research[1].
Product Specifications
CAS Number
[2991229-06-0]
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
FC(F)(C12CC(C2)(C3=NC(C4=C(C(NS(=O)(C5=C(C=CC=C5F)C(F)(F)F)=O)=CC=C4)F)=C(C6=NC(N[C@@H]7CC[C@H](CC7)S(C)(=O)=O)=NC=C6)S3)C1)F
Molecular Formula
C33H29F8N5O4S3
Molecular Weight
807.80
References & Citations
[1]Yan Lou. Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors. US20230303509. 2025-06-17.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SC205135 10 µg
Tartrate Resistant Acid Phosphatase (ACP5) (NM_001611) Human 3' UTR Clone
Ask
View Details 
GTR15338545 1 Vial
Lentiviral human CNKSR1 shRNA (UAS) - Lentiviral human CNKSR1 shRNA (UAS, GFP) plasmid
Ask
View Details